Anteo has another new employee, Rachel de las Heras, whom appears to have a background in biotech, life sciences, advanced technologies and most recently, commercialisation. Immediately before joining Anteo, Rachel worked as a commercialisation associate at Uniquest... a little about Uniquest from their website:
'UniQuest is one of Australia’s leading research commercialisation companies, specialising in global technology transfer and facilitating access for all business sectors to world class university expertise, intellectual property and facilities.
UniQuest's innovation portfolio includes Australia's first blockbuster vaccine Gardasil®, Australia's largest biotech IPO QRxPharma Ltd, the internationally acclaimed Triple P Positive Parenting Program, and UQ’s superconductor technology used in two-thirds of the world's MRI machines'
I do wonder what Rachel will be doing at Anteo?? ;)
ADO Price at posting:
6.9¢ Sentiment: LT Buy Disclosure: Held
